Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.81 |
| ▸ | TSHR | P16473 | 4/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.70 |
| ▸ | KDM4A | O75164 | 1/20 | 0.56 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8927962 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL167484 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| 2-Hydroxybenzoic Acid Hexyl Ester SCHEMBL113059 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL1005991 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL15685 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL2801630 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL8927603 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL2798676 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL1923016 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL411474 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116710059-A | Oral care compositions comprising hops and flavoring agents | 宝洁公司 | 2023-09-05 | — | — | CN | claimed |
| EP-4216915-A1 | ORAL CARE COMPOSITION COMPRISING HOPS AND FLAVOR | The Procter & Gamble Company (US) | 2023-08-02 | — | — | EP | claimed |
| US-20220096363-A1 | Oral Care Composition Comprising Hops And Flavor | THE PROCTER & GAMBLE COMPANY | 2022-03-31 | — | — | US | claimed |
| US-5993971-A | TRANSPARENT SUBSTRATE IS MADE OF A RESIN MATERIAL MAINLY CONSISTING OF A POLYCARBONATE RESIN THAT CONTAINS NO MORE THAN 4 WT % OF LOW MOLECULAR WEIGHT FRACTIONS IN ORDER TO AVOID A DOUBLE REFRACTION | SONY CORPORATION (JP) | 1999-11-30 | — | — | US | claimed |
| US-5559098-A | Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic | ROEHM PHARMA GMBH (DE) | 1996-09-24 | — | — | US | claimed |
| US-5075278-A | Pressure sensitive elements | EPACOR, INC. | 1991-12-24 | — | — | US | claimed |
| CN-119013028-A | Compositions and methods for ameliorating sexual dysfunction | 温桑托尔公司 | 2024-11-22 | — | — | CN | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| WO-2024204339-A1 | POSITIVE PHOTOSENSITIVE PIGMENT COMPOSITION, CURED PRODUCT, AND ORGANIC EL DISPLAY DEVICE | 東レ株式会社 | 2024-10-03 | — | — | WO | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| CN-116710059-A | Oral care compositions comprising hops and flavoring agents | 宝洁公司 | 2023-09-05 | — | — | CN | disclosed |
| EP-4216915-A1 | ORAL CARE COMPOSITION COMPRISING HOPS AND FLAVOR | The Procter & Gamble Company (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| EP-0371444-A2 | Aromatic polycarbonate resin composition for molding | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1990-06-06 | — | — | EP | disclosed |
| EP-0330685-A1 | CHROMOGENIC COPY SYSTEM AND METHODS | Vassiliades, Anthony E. (US) | 1989-09-06 | — | — | EP | disclosed |
| EP-0330685-A4 | CHROMOGENIC COPY SYSTEM AND METHODS. | VASSILIADES ANTHONY E | 1989-08-09 | — | — | EP | disclosed |
| EP-0303443-A2 | Multivalent metal-modified salicylic acid resins, and color-developing agents and copying paper using the resins | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-02-15 | — | — | EP | disclosed |
| WO-1989000506-A1 | CHROMOGENIC COPY SYSTEM AND METHODS | VASSILIADES ANTHONY E (US) | 1989-01-26 | — | — | WO | disclosed |
| US-4631334-A | AUDIO, VIDEO, MEMORY DISKS, OPTICAL READING LENSES | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1986-12-23 | — | — | US | disclosed |
| US-3945959-A | ELECTRICAL INSULATION, CONDUCTORS | THE P. D. GEORGE CO. (US) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096363-A1 | Oral Care Composition Comprising Hops And Flavor | TAS1R1, TAS1R3, FGF1 | ALDH1A1 3225/4885TSHR 3045/4885LMNA 3930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.